Table 1. Demographic and clinical data in all patients.
Data given as median and IQR.
| Consent (Group B)b | No consent (group A)a | |
|---|---|---|
| Patients | 1898 | 1200 |
| Countries | 15 | 7 |
| Age in years, median (IQR) | 84 (81–87) | 84 (81–86) |
| Gender (female) n (%) | 872 (45.9%) | 567 (47.2%) |
| SOFA, median (IQR) 1 | 6 (3–9) | 8 (5–10) |
| CFS, median (IQR) | 4 (1–9) | 4 (1–9) |
| IQCODE, median (IQR)1 | 3.19 (3–3.62) | 3,31 (3.06–4.0) |
| Katz ADL, median (IQR)1 | 6 (4–6) | 6 (3–6) |
| Mechanical ventilation n (%) 1 | 907 (47.7%) | 738 (61.6%) |
| Vasoactive drugs1 | 993(52.4%) | 894 (74.7%) |
| Withdrawal | 231 (12.3%) | 122 (10.3%) |
| ICU survival | 1484 (78.4%)1 | 787 (66.2%) |
1 p<0.0001.
SOFA = Sequential Organ Failure Assessment; CFS = Clinical Frailty Scale; IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly; ADL = Activity of Daily Life.
a Norway, Sweden, Poland, Greece, Libya, Austria and Netherland (partially)
b Denmark, Ireland, Wales, Germany, Belgium, France, Switzerland, Spain, Italy, Portugal, Ukraine, Russia, Turkey, Croatia, Netherlands (partially).